Status:

COMPLETED

Nutrition and LOComotoric Rehabilitation in Long COVID-19

Lead Sponsor:

Universitair Ziekenhuis Brussel

Collaborating Sponsors:

Vrije Universiteit Brussel

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Long COVID is a new phenomenon, in which individuals who experienced a SARS-CoV-2 infection still experience one or more symptoms, such as exercise intolerance, fatigue and/or muscle pains in addition...

Detailed Description

The rapid spread of SARS-CoV-2 virus has already led to more than 212 million confirmed cases. The acute phase of infection resulted in variable clinical presentations, from asymptomatic to severe ill...

Eligibility Criteria

Inclusion

  • Able to understand and sign written consent in Dutch, French or English
  • Laboratory (PCR and/or serology) confirmed infection with SARS-CoV-2 less than 12 months ago
  • Persisting functional difficulties and symptoms: exercise intolerance and/or fatigue and/or muscle pain beyond 12 weeks beside other COVID-related symptoms (e.g., loss of taste and/or smell)
  • Patient affiliated to a social security system

Exclusion

  • Patients unable to comprehend oral and/or written instructions, questionnaires in English, French or Dutch.
  • Patient currently suffers from any other disease beside long COVID that could explain the symptoms (e.g., fibromyalgia, Sjögren disease, severe anaemia...)
  • Patient is unable to undergo a rehabilitation programme due to comorbidities (e.g., major cardiovascular disease such as myocarditis or severe dementia), as decided on by the medical study team members.
  • Patient currently benefiting from physiotherapy sessions with focus on motor and/or respiratory therapy for COVID-19 or any other unrelated disease
  • Patients with metabolic disorders or severe gastro-intestinal conditions (e.g. short bowel syndrome)

Key Trial Info

Start Date :

April 24 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2024

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT05254301

Start Date

April 24 2022

End Date

January 30 2024

Last Update

May 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitair ziekenhuis Brussel

Brussels, Belgium, 1090